Investment
Features
FeesSafety
Academy
More
Pluang+

Compare FedEx Corporation (FDX) vs Mesoblast Limited (MESO) Price & Performance

FedEx CorporationTrade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

FedEx Corporation vs Mesoblast Limited — how do they compare? FedEx Corporation trades at $322.99 (market cap $76.28B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: FedEx Corporation is far larger — about 34.5× Mesoblast Limited's market cap, and FedEx Corporation pays a 1.51% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.

FDXMESO
Market Cap
$76.28B$2.21B
Sector
IndustrialsTechnology
52-Week High
$338.75$20.96
52-Week Low
$180.51$12.88
Enterprise Value
$105.91B$2.21B
Dividend Yield
1.51%

Returns comparison

Trailing returns across standard periods

About FedEx Corporation

FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.

Read more on FDX

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO